Showing results (51-60 of 156) with videos related to
Sort By:
Pageof 16
Breast Cancer Research and Treatment|September 29, 2006
Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinomaEriko Tokunaga, Eiji Oki, Yasue Kimura, et al.Anticancer Research|June 4, 2020
Efficacy of Adjuvant Combination Therapy With Trastuzumab and Chemotherapy in HER2-positive Early Breast Cancer: A Single Institutional Cohort Study from Clinical PracticeMasahiro Okamoto, Wakako Tajiri, Hiroki Ueo, et al.Breast Cancer (Tokyo, Japan)|September 6, 2021
Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapyEriko Tokunaga, Takanobu Masuda, Hideki Ijichi, et al.Breast (Edinburgh, Scotland)|November 19, 2015
Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancerEriko Tokunaga, Nami Yamashita, Hiroyuki Kitao, et al.Breast Cancer (Tokyo, Japan)|February 17, 2016
Aromatase inhibitors with or without luteinizing hormone-releasing hormone agonist for metastatic male breast cancer: report of four cases and review of the literatureSayaka Kuba, Mayumi Ishida, Masahiro Oikawa, et al.Breast Cancer (Tokyo, Japan)|October 18, 2021
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancerMasato Takahashi, Eriko Tokunaga, Joji Mori, et al.World Journal of Gastroenterology|May 27, 2009
Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancerEiji Oki, Yan Zhao, Rintaro Yoshida, et al.Annals of Surgical Oncology|April 25, 2012
FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancerRyota Nakanishi, Hiroyuki Kitao, Yoshihiko Fujinaka, et al.Annals of Surgical Oncology|December 20, 2011
Loss of heterozygosity at BRCA1 locus is significantly associated with aggressiveness and poor prognosis in breast cancerSatoko Okada, Eriko Tokunaga, Hiroyuki Kitao, et al.Journal of Cancer Research and Clinical Oncology|January 29, 2013
Vimentin as a poor prognostic factor for triple-negative breast cancerNami Yamashita, Eriko Tokunaga, Hiroyuki Kitao, et al.Pageof 16